Abstract
Purpose
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been used in adults with ovarian carcinoma proving overall survival benefit in randomized trials, but measured in months. Diffuse peritoneal disease from pediatric type ovarian tumors is rare. We applied CRS and HIPEC to pediatric girls with diffuse peritoneal disease as part of a clinical trial.
Methods
In all patients complete cytoreduction was followed by HIPEC using 100 mg/m2 of cisplatin for 90 min in a closed technique. All received neoadjuvant chemotherapy. Patients with disease outside of the abdominal cavity were excluded.
Results
Of 101 pediatric CRS and HIPEC operations, 8 had ovarian primary tumors and multifocal peritoneal disease. There were three yolk sac tumors (germ cell, mixed teratoma), one Sertoli–Leydig, one PNET of the ovary, one choriocarcinoma, one juvenile granulosa cell tumor and one adenocarcinoma. Age ranged 4–18 years. Three of the 8 (37 %) recurred and died. The remaining 63 % are disease free 2–6 years post HIPEC. Overall survival and relapse-free survival in this cohort was 64 and 62 %, respectively [CI 0.64 (0.34, 1); 0.62 (0.37, 1)].
Conclusions
This is the first report of CRS and HIPEC in pediatric ovarian tumors. HIPEC may be effective in pediatric-type ovarian tumors. More study is needed in a larger cohort.
This is a preview of subscription content, log in via an institution to check access.
References
de Bree E, Romanos J, Michalakis J et al (2003) Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin. Anticancer Res 23:3019–3027
Horowitz NS, Miller A, Rungruang B et al (2015) Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin Oncol 33:937–943
Imai A, Furui T, Tamaya T (1994) Gynecologic tumors and symptoms in childhood and adolescence; 10-years’ experience. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 45:227–234
Schultz KA, Sencer SF, Messinger Y et al (2005) Pediatric ovarian tumors: a review of 67 cases. Pediatr Blood Cancer 44:167–173
Hayes-Jordan A, Anderson P, Curley S et al (2007) Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor. J Pediatr Surg 42:E29–E32
Hayes-Jordan A, Anderson PM (2011) The diagnosis and management of desmoplastic small round cell tumor: a review. Curr Opin Oncol 23:385–389
Hayes-Jordan A, Green H, Fitzgerald N et al (2010) Novel treatment for desmoplastic small round cell tumor: hyperthermic intraperitoneal perfusion. J Pediatr Surg 45:1000–1006
Hayes-Jordan A, Green HL, Lin H et al (2014) Complete cytoreduction and HIPEC improves survival in desmoplastic small round cell tumor. Ann Surg Oncol 21:220–224
Hayes-Jordan A, Anderson P (2009) Desmoplastic small cell round tumor: review of therapy including surgery followed by continuous hyperthermic peritoneal perfusion of chemotherapy. Oncol Rev 3:195–200
Hayes-Jordan A, Green H, Ludwig J et al (2012) Toxicity of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric patients with sarcomatosis/carcinomatosis: early experience and phase 1 results. Pediatr Blood Cancer 59:395–397
Pectasides D, Pectasides E, Psyrri A (2008) Granulosa cell tumor of the ovary. Cancer Treat Rev 34:1–12
Gershenson DM (2007) Management of ovarian germ cell tumors. J Clin Oncol 25:2938–2943
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hayes-Jordan, A., Lopez, C., Green, H.L. et al. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric ovarian tumors: a novel treatment approach. Pediatr Surg Int 32, 71–73 (2016). https://doi.org/10.1007/s00383-015-3814-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-015-3814-9